05/09/2024 6:37 AM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 3:35 PM | Sensei Biotherapeutics (Filer)
| Form DEFA14A | |
04/29/2024 3:40 PM | Sensei Biotherapeutics (Filer)
| Form ARS | |
04/12/2024 3:31 PM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 6:45 AM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2024 5:00 PM | Newtyn Management, LLC (Filed by) Sensei Biotherapeutics (Subject)
| Form SC 13D/A | |
02/29/2024 3:44 PM | Sensei Biotherapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
02/28/2024 6:31 AM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 5:25 PM | Colgan Erin (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 5:28 PM | Celebi John (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 5:37 PM | Sensei Biotherapeutics (Issuer) van der Horst Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 4:34 PM | Newtyn Management, LLC (Filed by) Sensei Biotherapeutics (Subject)
| Form SC 13D/A | |
01/04/2024 7:14 AM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 3:40 PM | Sensei Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 6:35 AM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 5:07 AM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:50 PM | Krebs Stephanie (Reporting) Sensei Biotherapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/02/2023 3:53 PM | Krebs Stephanie (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/20/2023 4:01 PM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 7:43 AM | Celebi John (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 4:31 PM | Colgan Erin (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 4:33 PM | Celebi John (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 4:33 PM | Sensei Biotherapeutics (Issuer) van der Horst Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 4:34 PM | Gallagher Patrick Stephen (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/17/2023 4:15 PM | Sensei Biotherapeutics (Filer)
| Form 424B5 | |
08/04/2023 3:41 PM | Cambrian BioPharma Inc (Filed by) Sensei Biotherapeutics (Subject)
| Form SC 13G/A | |
08/03/2023 3:32 PM | Sensei Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023 7:45 AM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2023 4:00 PM | Broder Samuel (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 4:02 PM | RICKS THOMAS G (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 4:03 PM | RINGO WILLIAM R (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 3:44 PM | Holmen Bob (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 3:46 PM | Sensei Biotherapeutics (Issuer) Vojta Deneen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 3:48 PM | English Jessie (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 3:50 PM | Humer Kristian (Reporting) Sensei Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2023 3:31 PM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/27/2023 8:00 AM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 3:30 PM | Sensei Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2023 3:41 PM | Sensei Biotherapeutics (Filer)
| Form ARS | |
06/15/2023 3:31 PM | Sensei Biotherapeutics (Filer)
| Form DEF 14A | |
05/23/2023 3:50 PM | Apeiron Investment Group Ltd. (Filed by) Sensei Biotherapeutics (Subject)
| Form SC 13D/A | |
348 million Americans lives to END as we know it? (Ad) 348 million American lives are about to change FOREVER....
Because thanks to one shocking A.I. development I'm revealing for the first time today... To see my free research, simply click here now. |
05/23/2023 3:30 PM | Sensei Biotherapeutics (Filer)
| Form DEFA14A | |